Literature DB >> 4025369

Pneumonia caused by gram-negative bacilli.

A Karnad, S Alvarez, S L Berk.   

Abstract

Gram-negative bacillary pneumonia has become an increasingly important disease in immunosuppressed, elderly, and hospitalized patients. The clinical features, etiologic agents, population at risk, treatment, and outcome in patients with well-documented gram-negative pneumonia were compared in two groups of patients: those with bacteremic pneumonia and those with nonbacteremic pneumonia documented by transtracheal aspiration. Clinical features were frequently subtle in both groups. A wide range of gram-negative bacilli were implicated as pathogens and pneumonias documented by transtracheal aspiration were frequently mixed infections. Pseudomonas aeruginosa and Serratia marcescens were the most common pathogens causing bacteremic pneumonias, whereas Escherichia coli and Klebsiella were more common in the nonbacteremic group. Gram-negative bacillary pneumonia was frequently a lethal disease despite two-drug therapy, particularly in bacteremic patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025369     DOI: 10.1016/0002-9343(85)90193-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Emerging pathogens in nosocomial pneumonia.

Authors:  S L Berk; A Verghese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

2.  Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.

Authors:  D J Weber; S B Calderwood; A W Karchmer; J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 3.  Lung humoral response to Pseudomonas species.

Authors:  R B Fick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

4.  Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.

Authors:  D Williams; M Perri; M J Zervos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

5.  [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].

Authors:  K Unertl; G Ruckdeschel; H Forst; F P Lenhart
Journal:  Infection       Date:  1986       Impact factor: 3.553

6.  Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia.

Authors:  Alexandre Boyer; Brice Amadeo; Frédéric Vargas; Ma Yu; Sylvie Maurice-Tison; Véronique Dubois; Cécile Bébéar; Anne Marie Rogues; Didier Gruson
Journal:  BMC Infect Dis       Date:  2011-05-11       Impact factor: 3.090

7.  Anemoside B4 protects against Klebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice.

Authors:  Jia He; Renyikun Yuan; Xiaolan Cui; Yushun Cui; Shan Han; Qin-Qin Wang; Yangling Chen; Liting Huang; Shilin Yang; Qiongming Xu; Yonghui Zhao; Hongwei Gao
Journal:  Chin Med       Date:  2020-07-02       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.